Citation: Cj. Mcginn et Mm. Zalupski, Combined-modality therapy in pancreatic cancer: Current status and future directions, CANCER J, 7(4), 2001, pp. 338-348
Citation: Km. Leu et Mm. Zalupski, Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed, ONCOLOGY-NY, 15(10), 2001, pp. 1259-1260
Authors:
McGinn, CJ
Zalupski, MM
Shureiqi, I
Robertson, JM
Eckhauser, FE
Smith, DC
Brown, D
Hejna, G
Strawderman, M
Normolle, D
Lawrence, TS
Citation: Cj. Mcginn et al., Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer, J CL ONCOL, 19(22), 2001, pp. 4202-4208
Authors:
Philip, PA
Zalupski, MM
Vaitkevicius, VK
Arlauskas, P
Chaplen, R
Heilbrun, LK
Adsay, V
Weaver, D
Shields, AF
Citation: Pa. Philip et al., Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma, CANCER, 92(3), 2001, pp. 569-577
Authors:
Ahmed, S
Vaitkevicius, VK
Zalupski, MM
Du, W
Arlauskas, P
Gordon, C
Kellogg, C
Shields, AF
Citation: S. Ahmed et al., Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma - A phase II study, AM J CL ONC, 23(4), 2000, pp. 420-424
Authors:
Jimenez, RE
Zalupski, MM
Frank, JJ
Du, W
Ryan, JR
Lucas, DR
Citation: Re. Jimenez et al., Multidrug resistance phenotype in high grade soft tissue sarcoma - Correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy, CANCER, 86(6), 1999, pp. 976-981
Authors:
Leichman, CG
Jacobson, JR
Modiano, M
Daniels, JR
Zalupski, MM
Doroshow, JH
Fletcher, WS
Macdonald, JS
Citation: Cg. Leichman et al., Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma - A Southwest Oncology Group pilot trial, CANCER, 86(5), 1999, pp. 775-781